Who we are

Development and commercialisation of new curative anti-malarial treatments.


Marc Mommaerts

Marc Mommaerts holds an MSc and a Master’s degree in Financial Manangment. He has been Arenco’s CEO since the effective re-start in 2001. He also sits on the board at other emerging technology companies in the area.


Roel Verstraeten

Roel holds a Master Degree in Applied Economics. He brings over 25 years of experience in pharmaceutical business development with Johnson&Johnson and shares a passion for Africa with the rest of the team.


Our development team

Our development team, located at premises of Brussels University, (Center for Pharmaceutical Research) specializes in formulations research. We hold regular meetings with our African partners to keep in touch with the needs of our markets.

click on picture to view enlarged version


© 2011-2014 Arenco Pharmaceutica NV